Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative Review
Bacterial infections are common events that significantly impact the clinical course of patients with cirrhosis. As in the general population, infections caused by multi-drug-resistant organisms (MDROs) are progressively increasing in cirrhotic patients, accounting for up to 30–35% of all infections...
Main Authors: | Lorenzo Onorato, Caterina Monari, Salvatore Capuano, Pierantonio Grimaldi, Nicola Coppola |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/2/232 |
Similar Items
-
AMXT-1501 targets membrane phospholipids against Gram-positive and -negative multidrug-resistant bacteria
by: Jinxin Zheng, et al.
Published: (2024-12-01) -
Bloodstream Infection Due to a VIM-Metallo-β-Lactamase-Producing Klebsiella pneumoniae Treated with Cefiderocol in a Preterm Newborn
by: Caterina Monari, et al.
Published: (2022-12-01) -
Approach to multidrug resistant infections in pediatric transplant recipients
by: Sara W. Dong, et al.
Published: (2023-12-01) -
Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017–2018)
by: Sirigade Ruekit, et al.
Published: (2022-08-01) -
Comparison of Risk Stratification Approaches to Identify Patients with Clostridioides difficile Infection at Risk for Multidrug-Resistant Organism Gut Microbiota Colonization
by: Evan J. Zasowski, et al.
Published: (2023-07-01)